NorthEdge Invests in Distology
March 2, 2021
NorthEdge has made a growth capital investment in Distology, a Manchester/Stockport-based value-added cybersecurity distributor, to support the company's service expansion and European growth. The investment is funded from NorthEdge's £120m SME Fund and will back CEO Hayley Roberts and the management team while expanding the firm's services, vendor relationships and European presence.
- Buyers
- NorthEdge
- Targets
- Distology
- Industry
- Cybersecurity
- Location
- England, United Kingdom
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Distology Acquires Squareball Digital
September 8, 2022
Cybersecurity
Distology has acquired Germany-based Squareball Digital, a specialist in Identity and Access Management, as a bolt-on to expand its security services in Europe. The acquisition was supported by Distology's investor NorthEdge and strengthens Distology's IAM capabilities and presence in the German market.
-
NorthEdge Invests in Helios Medical Communications
January 14, 2021
Healthcare Services
NorthEdge, a UK private equity firm, has made a growth investment in Helios Medical Communications to support the agency's UK and international expansion plans. The Cheshire-headquartered medical communications agency will use the funding to expand offices (including a new Manchester location), recruit talent, and pursue international growth; NorthEdge partners will join the Helios board.
-
NorthEdge Invests in Friend MTS
September 6, 2022
Cybersecurity
NorthEdge has completed an investment into Friend MTS, a Birmingham-headquartered provider of video content security and anti-piracy solutions. The funding (from NorthEdge Fund III alongside co-investors) will support product investment, hiring and global expansion, and NorthEdge will join the Friend MTS board to help accelerate growth.
-
NorthEdge Invests in Torbay Pharmaceuticals
November 20, 2023
Pharmaceuticals
NorthEdge has acquired Torbay Pharmaceuticals, a UK-based sterile injectable contract manufacturer, from Torbay and Devon NHS Foundation Trust to support the company's next phase of international growth. The investment (funded by NorthEdge Fund III) will back expansion into North America, strengthen fill/finish and plastic vial capabilities, increase automation, and support growth of Torbay's c.250-strong team at its Paignton, Devon HQ.
-
NorthEdge Completes Multi‑Million‑Pound Investment into Antibody Analytics
November 2, 2023
Biotechnology
NorthEdge has completed a multi‑million‑pound growth investment in Antibody Analytics (now trading as RoukenBio), a Scotland‑based pre‑clinical immunology CRO. The capital will fund site expansion, upgraded facilities and job creation as NorthEdge (represented on the board by Liam May) backs CEO Andy Upsall and the leadership team to scale the business internationally.
-
NorthEdge Backs Management Buyout of Altia-ABM
November 25, 2020
Software
NorthEdge has invested via its SME fund to support a primary management buyout of Altia-ABM, a UK-based specialist investigation and covert operations software business. The investment will fund product and cloud development, expand Altia-ABM's addressable market into additional private-sector customers and international territories, and support potential strategic acquisitions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.